Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate, 95.0%, 5g

[1,2,4]triazolo[4,3-a]pyridine-7-carboxylic acid, 95.0%, 5g

[(2-methylphenyl)(4-pyridinyl)methyl]amine dihydrochloride, 95.0%, 1g

1-(4-Aminopiperidin-1-yl)-2-methylpropan-1-one hydrochloride, 95.0%, 250mg

ROTI®Fair 0.5M EDTA

[(3-phenoxyphenyl)methyl](prop-2-en-1-yl)amine, 95.0%, 10g

2-carboethoxy-3'-thiomorpholinomethyl benzophenone, 97.0%, 1g

Hexylamine>99.0%(GC)(T)25mL

4-Chlorobenzoyl Chloride>98.0%(GC)(T)25g

2-imino-4-(1H-indol-3-yl)-7,7-dimethyl-5-oxo-3,4,5,6,7,8-hexahydro-2H-1-benzopyran-3-carbonitrile, 90%, 1g

CANAGLIFLOZIN, 95%, 100mg

2-Methyl-2H-1,2,3-triazol-4-amine, 98+%, 5g

4,4'-Dimethyl-2,2'-bipyridyl 1-Oxide>98.0%(GC)5g